NO165917C - Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn.

Info

Publication number
NO165917C
NO165917C NO870128A NO870128A NO165917C NO 165917 C NO165917 C NO 165917C NO 870128 A NO870128 A NO 870128A NO 870128 A NO870128 A NO 870128A NO 165917 C NO165917 C NO 165917C
Authority
NO
Norway
Prior art keywords
difluorhex
preparation
therapeutic active
analogy procedure
active diamino
Prior art date
Application number
NO870128A
Other languages
English (en)
Norwegian (no)
Other versions
NO870128D0 (no
NO165917B (no
NO870128L (no
Inventor
Michael Kolb
David A Kendrick
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO870128D0 publication Critical patent/NO870128D0/no
Publication of NO870128L publication Critical patent/NO870128L/no
Publication of NO165917B publication Critical patent/NO165917B/no
Publication of NO165917C publication Critical patent/NO165917C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/24Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/23Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton containing carbon-to-carbon triple bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO870128A 1986-01-14 1987-01-13 Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn. NO165917C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/818,848 US4707498A (en) 1986-01-14 1986-01-14 Fluorinated diaminoalkyne derivatives

Publications (4)

Publication Number Publication Date
NO870128D0 NO870128D0 (no) 1987-01-13
NO870128L NO870128L (no) 1987-07-15
NO165917B NO165917B (no) 1991-01-21
NO165917C true NO165917C (no) 1991-05-02

Family

ID=25226588

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870128A NO165917C (no) 1986-01-14 1987-01-13 Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn.

Country Status (20)

Country Link
US (1) US4707498A (de)
EP (1) EP0229658B1 (de)
JP (1) JP2520244B2 (de)
KR (1) KR900006748B1 (de)
CN (1) CN1013491B (de)
AR (1) AR241898A1 (de)
AT (1) ATE55596T1 (de)
AU (1) AU589245B2 (de)
CA (1) CA1269996A (de)
DE (1) DE3764276D1 (de)
DK (1) DK14987A (de)
ES (1) ES2016570B3 (de)
FI (1) FI85582C (de)
GR (1) GR3000786T3 (de)
HU (1) HU199772B (de)
IL (1) IL81213A (de)
NO (1) NO165917C (de)
NZ (1) NZ218890A (de)
PT (1) PT84100B (de)
ZA (1) ZA87159B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085845B2 (ja) * 1987-05-12 1996-01-24 住友化学工業株式会社 エステル化合物およびそれを有効成分とする殺虫剤
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
IL97759A0 (en) * 1990-04-11 1992-06-21 Ciba Geigy Ag Hydroxylamine compounds
IL121789A (en) * 1996-10-03 2001-06-14 Rohm & Haas A medicinal product for inhibiting mammalian cell tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139563A (en) * 1977-07-01 1979-02-13 Merrell Toraude Et Compagnie α-ACETYLENIC DERIVATIVES OF AMINES
US4193563A (en) * 1977-12-01 1980-03-18 Carmen Vitale Apparatus for carrying and dispensing cable
IE54304B1 (en) * 1981-08-19 1989-08-16 Merrell Dow France Fluorinated diamino-heptene and -heptyne derivatives
US4421768A (en) * 1982-08-11 1983-12-20 Merrell Toraude Et Compagnie Fluorinated diamino-heptene and-heptyne derivatives

Also Published As

Publication number Publication date
NO870128D0 (no) 1987-01-13
GR3000786T3 (en) 1991-10-10
AU589245B2 (en) 1989-10-05
ZA87159B (en) 1987-08-26
AU6747787A (en) 1987-07-16
AR241898A1 (es) 1993-01-29
HU199772B (en) 1990-03-28
KR900006748B1 (ko) 1990-09-20
DK14987D0 (da) 1987-01-13
KR870007098A (ko) 1987-08-14
EP0229658B1 (de) 1990-08-16
NZ218890A (en) 1989-10-27
EP0229658A1 (de) 1987-07-22
IL81213A0 (en) 1987-08-31
NO165917B (no) 1991-01-21
NO870128L (no) 1987-07-15
ATE55596T1 (de) 1990-09-15
CN1013491B (zh) 1991-08-14
DK14987A (da) 1987-07-15
DE3764276D1 (de) 1990-09-20
ES2016570B3 (es) 1990-11-16
CN87100255A (zh) 1987-09-30
FI870139A (fi) 1987-07-15
IL81213A (en) 1990-08-31
FI85582B (fi) 1992-01-31
JP2520244B2 (ja) 1996-07-31
FI85582C (fi) 1992-05-11
PT84100B (pt) 1989-02-28
FI870139A0 (fi) 1987-01-14
CA1269996A (en) 1990-06-05
HUT46650A (en) 1988-11-28
PT84100A (en) 1987-02-01
US4707498A (en) 1987-11-17
JPS62167744A (ja) 1987-07-24

Similar Documents

Publication Publication Date Title
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO165344C (no) Analogifremgangsmaate for fremstilling av teraputisk aktive indolizin-derivater.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
NO875082D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO871588L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO163184C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO863671L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
NO875488L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO163486C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater.
NO873108D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO165104C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater.
NO873835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO165917C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn.